COM:ERYTECH
PHAXIAM Therapeutics
- Stock
Last Close
0.80
28/06 15:35
Market Cap
48.66M
Beta: -
Volume Today
27.49K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Sep '18 | Dec '18 | Sep '19 | Dec '19 | Jun '21 | Dec '21 | Jun '22 | Sep '22 | Dec '22 | Mar '23 | Jun '23 | Sep '23 | Dec '23 | Mar '24 | Jun '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -10.68M - | -8.57M 19.70% | -13.97M 62.92% | -19.40M 38.89% | -27.95M 44.06% | -25.84M 7.54% | -1.02M 96.04% | -5.14M 401.86% | 796K 115.49% | -6.10M 866.39% | -12.20M 100% | -5.69M 53.36% | -11.29M 98.37% | -5.32M 52.89% | -5.32M 0% | |
depreciation and amortization | 168K - | 171K 1.79% | 908K 430.99% | 2.21M 143.72% | 2.49M 12.65% | 2.88M 15.72% | 4.29M 48.70% | 1.67M - | 105.50K 93.67% | 261K 147.39% | 469K - | 370K - | ||||
deferred income tax | -723K - | -845K 16.87% | -2.40M 183.43% | 2.38M 199.33% | 2K - | 3.74M 186,750% | -3.22M - | -208K - | ||||||||
stock based compensation | 574K - | 495K 13.76% | 259K 47.68% | 351K 35.52% | -326K - | 447K 237.12% | 195K 56.38% | -390K - | ||||||||
change in working capital | -7.40M - | 7.63M 203.13% | 2.22M 70.94% | 7.70M 247.25% | -6.93M 189.96% | -224K 96.77% | -2.97M 1,227.68% | -5.12M - | -186.50K 96.36% | 321K 272.12% | -2.39M - | 59K - | ||||
accounts receivables | -10K - | 2K 120% | -278K 14,000% | 215K - | 38K 82.33% | 76K 100% | 142K - | -152K - | ||||||||
inventory | 46K - | -1.18M 2,671.74% | 36K 103.04% | -187K 619.44% | ||||||||||||
accounts payables | -3.64M - | -2.84M 22.01% | -2.35M 17.16% | -6.87M - | 694K - | -1.91M - | -1.14M - | |||||||||
other working capital | -7.45M - | 8.82M 218.38% | 2.18M 75.25% | 7.89M 261.55% | -3.28M 141.58% | 2.61M 179.63% | -345K 113.21% | 1.53M - | -224.50K 114.66% | -449K 100% | -626K - | 1.35M - | ||||
other non cash items | -119K - | 119K 200% | 122K 2.52% | 124K 1.64% | 8.26M 6,564.52% | 7.40M 10.42% | -13.71M 285.15% | 5.46M 139.87% | 4.76M 12.83% | 39K 99.18% | -239K 712.82% | 6.08M 2,643.93% | 3.36M 44.69% | 5.32M 58.12% | 5.32M 0% | |
net cash provided by operating activities | -18.18M - | -1.00M 94.49% | -12.86M 1,183.23% | -6.63M 48.41% | -32.76M 393.80% | -24.39M 25.56% | -20.89M 14.34% | -11.10M - | -5.95M 46.42% | -11.82M 98.71% | -12.55M - | -8.34M - | ||||
investments in property plant and equipment | -855K - | -11.97M 1,299.77% | -1.94M 83.77% | -540K 72.21% | -146K 72.96% | -152K 4.11% | -7K 95.39% | -78K - | -26.50K 66.03% | -53K 100% | -164K - | -437K - | ||||
acquisitions net | 37.63M - | 1K - | 10K - | 22K - | 8K - | |||||||||||
purchases of investments | -59K - | -135K 128.81% | -119K 11.85% | -130K - | -62K 52.31% | -5K 91.94% | -4K - | |||||||||
sales maturities of investments | 309K - | 25K 91.91% | 2K 92% | 143K 7,050% | 329K 130.07% | 257K - | 233K - | 127K - | 134K - | |||||||
other investing activites | 121.50K - | 1K - | ||||||||||||||
net cash used for investing activites | -914K - | -12.10M 1,224.18% | -1.75M 85.52% | -515K 70.62% | -274K 46.80% | -71K 74.09% | 37.95M 53,546.48% | 180K - | 95K 47.22% | 190K 100% | -19K - | -458K - | ||||
debt repayment | -192K - | -208K 8.33% | -452K 117.31% | -377K 16.59% | -5.71M 1,415.12% | -6.45M 12.83% | -3.09M 52.09% | -3.09M - | -1.28M - | -1.44M - | ||||||
common stock issued | 29.32M - | 5.31M 81.89% | ||||||||||||||
common stock repurchased | ||||||||||||||||
dividends paid | ||||||||||||||||
other financing activites | 113K - | -113K 200% | -9K 92.04% | 36K 500% | -809.50K - | -393K - | ||||||||||
net cash used provided by financing activities | -79K - | -321K 306.33% | -461K 43.61% | -341K 26.03% | 34.20M 10,129.91% | 10.88M 68.18% | 2.18M 79.96% | -3.73M - | -809.50K 78.27% | -1.70M 109.51% | -2.08M - | -393K - | ||||
effect of forex changes on cash | 685K - | 865K 26.28% | 2.55M 194.45% | -1.26M 149.63% | -138K - | |||||||||||
net change in cash | -18.49M - | -12.56M 32.07% | -12.53M 0.28% | -8.75M 30.11% | 1.88M 121.44% | -12.62M 772.56% | 19.64M 255.58% | -14.55M - | -6.80M 53.26% | -13.60M 100% | -14.71M - | -9.01M - | ||||
cash at beginning of period | 165.42M - | 146.93M 11.18% | 94.45M 35.72% | 81.93M 13.26% | 44.45M 45.75% | 46.32M 4.22% | 33.70M 27.25% | 53.34M - | 38.79M - | 25.19M - | 10.47M - | |||||
cash at end of period | 146.93M - | 134.37M 8.55% | 81.93M 39.03% | 73.17M 10.69% | 46.32M 36.69% | 33.70M 27.25% | 53.34M 58.28% | 38.79M - | -6.80M 117.53% | 25.19M 470.43% | 10.47M - | 1.46M - | ||||
operating cash flow | -18.18M - | -1.00M 94.49% | -12.86M 1,183.23% | -6.63M 48.41% | -32.76M 393.80% | -24.39M 25.56% | -20.89M 14.34% | -11.10M - | -5.95M 46.42% | -11.82M 98.71% | -12.55M - | -8.34M - | ||||
capital expenditure | -855K - | -11.97M 1,299.77% | -1.94M 83.77% | -540K 72.21% | -146K 72.96% | -152K 4.11% | -7K 95.39% | -78K - | -26.50K 66.03% | -53K 100% | -164K - | -437K - | ||||
free cash flow | -19.04M - | -12.97M 31.86% | -14.80M 14.12% | -7.17M 51.53% | -32.91M 358.67% | -24.54M 25.43% | -20.89M 14.85% | -11.18M - | -5.97M 46.56% | -11.87M 98.71% | -12.71M - | -8.77M - |
All numbers in (except ratios and percentages)